RN7SL408P

Across TCGA pan-cancer cohorts, RN7SL408P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RN7SL408P’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where RN7SL408P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL408P is over-expressed in tumor, although a few such as STAD and LUSC show the opposite, repressed pattern.

PRAD, STAD, and LUSC are the cancer types where RN7SL408P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL408P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	+0.069	.023	2	view →
STAD	Male	All	−0.216	.047	1	view →
LUSC	Female	All	−0.083	.018	1	view →
KIRC	Female	All	+0.046	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RN7SL408P–PRAD

Open the PRAD breakdown →